Tissue-colonizing disseminated tumor cells secrete prostaglandin E2 to promote NK cell dysfunction and evade anti-metastatic immunity
Cell Reports · 2024-11 · 43 (11) · 114855
DOI: 10.1016/j.celrep.2024.114855 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cell Reports, 2024-11. Verfasst von Anna-Marie Pedde und 20 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Molecular Immunology, School of Medicine and Health, Technical University of Munich (TUM), Munich, Germany. Hauptthemen laut MEDLINE: Killer Cells, Natural, Dinoprostone. Die Arbeit wurde bisher 25-mal zitiert (Crossref) und nennt 83 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Elite Network of Bavaria, German Cancer Aid, German Research Foundation.
Abstract (Originalsprache)
Natural killer (NK) cells are critical for anti-metastatic immunity and can eliminate metastasizing tumor cells within circulation and sites of metastatic seeding. Here, we show that disseminated tumor cells (DTCs) colonizing the mouse lung secrete prostaglandin E2 (PGE2) to locally induce NK cell dysfunction, allowing outgrowing metastases to escape immune control and establish metastatic disease. Mechanistically, PGE2 signaling through its receptors EP2 and EP4 mediates NK cell dysfunction, which leads to reprogramming of NK cell gene expression and results in impaired production of anti-metastatic cytokines. In human cancer patients, the PGE2-EP2/EP4 axis is associated with NK cell dysfunction within distant organ metastases. Disabling EP2/EP4 signaling in NK cells prevents their dysfunction in DTC-colonized lungs and achieves effective NK cell-mediated control of metastatic disease. Our findings reveal a suppressive signaling axis exploited by metastasizing tumor cells to escape immune control in distant organs that could be targeted for metastatic cancer therapy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institute of Molecular Immunology, School of Medicine and Health, Technical University of Munich (TUM), Munich, Germany.
- Immunology Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
- Institute of Molecular Oncology and Functional Genomics, School of Medicine and Health, TUM, Munich, Germany.
- Department of Surgery, School of Medicine and Health, TUM, Munich, Germany.
- Department of Surgery, School of Medicine and Health, TUM, Munich, Germany; Department of Surgery, University Clinic Tübingen, M3 Research Center, Tübingen, Germany.
- Cancer Immunology Program, Peter MacCallum Cancer Centre, 305 Grattan St., Melbourne, VIC, Australia.
Förderung
- Elite Network of Bavaria
- German Cancer Aid
- German Research Foundation
Zitieren
APA
Pedde, A. M., Kim, H., Donakonda, S., Baumann, T., Bayerl, F., Meiser, P., Hirschberger, A., Klement, C., Grassmann, S., Öllinger, R., Hüser, N., Hartmann, D., Laschinger, M., Trapani, J. A., Zippelius, A., Bald, T., Wiedemann, G. M., Rad, R., Sun, J. C., …, & Böttcher, J. P. (2024). Tissue-colonizing disseminated tumor cells secrete prostaglandin E2 to promote NK cell dysfunction and evade anti-metastatic immunity. Cell Reports, 43(11), 114855. https://doi.org/10.1016/j.celrep.2024.114855
Vancouver
Pedde AM, Kim H, Donakonda S, Baumann T, Bayerl F, Meiser P, et al. Tissue-colonizing disseminated tumor cells secrete prostaglandin E2 to promote NK cell dysfunction and evade anti-metastatic immunity. Cell Reports. 2024;43(11):114855. doi:10.1016/j.celrep.2024.114855
BibTeX
@article{Pedde2024,
author = {Pedde, Anna-Marie and Kim, Hyunu and Donakonda, Sainitin and Baumann, Tobias and Bayerl, Felix and Meiser, Philippa and Hirschberger, Anna and Klement, Christine and Grassmann, Simon and Öllinger, Rupert and Hüser, Norbert and Hartmann, Daniel and Laschinger, Melanie and Trapani, Joseph A and Zippelius, Alfred and Bald, Tobias and Wiedemann, Gabriela M and Rad, Roland and Sun, Joseph C and Höchst, Bastian and Böttcher, Jan P},
title = {Tissue-colonizing disseminated tumor cells secrete prostaglandin E2 to promote NK cell dysfunction and evade anti-metastatic immunity},
journal = {Cell Reports},
year = {2024},
volume = {43},
number = {11},
pages = {114855},
doi = {10.1016/j.celrep.2024.114855}
}
EUVIMED